SCHEMBL13259841

SCHEMBL13259841

Cn1cc(-c2cnc(N)c3nc(C4CCNCC4)cn23)cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 1/20 0.50
▸ AURKB Q96GD4 1/20 0.50
▸ CHEK1 O14757 9/20 0.45
▸ CCNA2 P20248 5/20 0.45
▸ CDK2 P24941 5/20 0.45
▸ CCNA1 P78396 5/20 0.45
▸ PIM1 P11309 3/20 0.41
▸ IRAK4 Q9NWZ3 3/20 0.41
▸ PIM3 Q86V86 2/20 0.41
▸ PIM2 Q9P1W9 2/20 0.41
▸ CHEK2 O96017 1/20 0.40
▸ TYRO3 Q06418 1/20 0.39
▸ MAP4K3 Q8IVH8 1/20 0.38
▸ IRAK1 P51617 1/20 0.38
▸ DYRK1A Q13627 2/20 0.37
▸ CLK1 P49759 1/20 0.37
▸ CLK2 P49760 1/20 0.37
▸ HIPK1 Q86Z02 1/20 0.37
▸ HIPK2 Q9H2X6 1/20 0.37
▸ HIPK3 Q9H422 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13764203 0.93 CHEK1 (0.49) AURKAAURKBCHEK1CCNA2CDK2
SCHEMBL13764205 0.87 CHEK1 (0.57) CHEK1CCNA2CDK2CCNA1PIM1
SCHEMBL14346919 0.82 AURKB (0.48) AURKAAURKBCHEK1CHEK2
SCHEMBL15146178 0.78 CHEK1 (0.55) CHEK1CCNA2CDK2CCNA1PIM1
SCHEMBL14536770 0.77 AURKB (0.69) AURKAAURKBCHEK1CCNA2CDK2
SCHEMBL14346920 0.76 AURKB (0.45) AURKAAURKBCHEK1CHEK2IRAK1
SCHEMBL13764302 0.75 CHEK1 (0.51) CHEK1CCNA2CDK2CCNA1PIM1
SCHEMBL12404449 0.74 AURKB (0.64) AURKAAURKBCHEK1PIM1PIM3
SCHEMBL8239888 0.74 AURKA (0.70) AURKAAURKBCHEK1CCNA2CDK2
SCHEMBL8248254 0.71 AURKB (0.53) AURKAAURKBCHEK1TYRO3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010088368-A2 IMIDAZOPYRAZINES AS PROTEIN KINASE INHIBITORS SCHERING CORPORATION (US) 2010-08-05 — — WO disclosed
US-20090175852-A1 IMIDAZOPYRAZINES AS PROTEIN KINASE INHIBITORS SCHERING CORPORATION 2009-07-09 — — US disclosed
US-20090175852-A1 IMIDAZOPYRAZINES AS PROTEIN KINASE INHIBITORS SCHERING CORPORATION 2009-07-09 — — US disclosed
US-7557104-B2 Imidazopyrazines as protein kinase inhibitors SCHERING CORPORATION (US) 2009-07-07 — — US disclosed
US-7557104-B2 Imidazopyrazines as protein kinase inhibitors SCHERING CORPORATION (US) 2009-07-07 — — US disclosed
US-20080027063-A1 IMIDAZOPYRAZINES AS PROTEIN KINASE INHIBITORS SCHERING CORPORATION 2008-01-31 — — US disclosed
US-20080027063-A1 IMIDAZOPYRAZINES AS PROTEIN KINASE INHIBITORS SCHERING CORPORATION 2008-01-31 — — US disclosed
WO-2007145921-A1 IMIDAZOPYRAZINES AS PROTEIN KINASE INHIBITORS SCHERING CORPORATION (US) 2007-12-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027063-A1 IMIDAZOPYRAZINES AS PROTEIN KINASE INHIBITORS CHEK1, CHEK2, CDKN1A AURKA 41/4885AURKB 138/4885CHEK1 1/4885
US-20090175852-A1 IMIDAZOPYRAZINES AS PROTEIN KINASE INHIBITORS CHEK1, CHEK2, CDKN1A AURKA 41/4885AURKB 138/4885CHEK1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback